Skip to main content

Butylated Hydroxyanisole vs Tertiary Butylhydroquinone: which is worse?

Quick answer: Tertiary Butylhydroquinone carries the heavier risk profile. Butylated Hydroxyanisole is in the EU and in the US; Tertiary Butylhydroquinone is in the EU and in the US.

PropertyButylated HydroxyanisoleTertiary Butylhydroquinone
EU status
US status
Risk level
Banned inJapan (banned for foods containing fats and oils)Japan (banned for food use)
Restricted inEuropean Union (restricted; banned in baby food), United KingdomEuropean Union (banned in baby foods; restricted in fats/oils to 100-200 mg/kg), United Kingdom, Australia
Categoryadditiveadditive
Where it hides

What is Butylated Hydroxyanisole?

Butylated hydroxyanisole (BHA) is a synthetic phenolic antioxidant preservative derived from petroleum (see also bha entry). It is a mixture of 2-BHA and 3-BHA isomers, used to prevent oxidative rancidity in fats, oils, and fat-containing foods. Chemical formula C11H16O2.

What is Tertiary Butylhydroquinone?

Tertiary butylhydroquinone (TBHQ) is a synthetic phenolic antioxidant preservative derived from butane. It is one of the most potent antioxidants for polyunsaturated fats and oils and is commonly used in fast-food frying oils. Its chemical formula is C10H14O2.

Documented risks

Butylated Hydroxyanisole: IARC classifies BHA as Group 2B (possible human carcinogen) based on forestomach tumor studies in rodents at high doses. The NTP lists it as 'reasonably anticipated to be a human carcinogen.' EFSA's 2012 review found endocrine-disrupting potential. Japan banned it for food use. The FDA permits it at 0.02% of fat content. Concerns about estrogen-receptor interaction have been documented in animal studies. Contact dermatitis from cosmetic use is reported.

Tertiary Butylhydroquinone: At high doses in animal studies, TBHQ has been shown to cause precancerous stomach lesions (squamous cell hyperplasia) in female rats. A study in Food and Chemical Toxicology documented these dose-dependent precancerous changes. The FDA limits TBHQ to 0.02% of fat content, reflecting dose-dependent safety thresholds. Immune function concerns emerged from research published around 2019-2020. A study (Farouk Musa and colleagues) found that TBHQ impaired the adaptive immune response to influenza in mouse models, including reduced effectiveness of influenza vaccination. EWG highlighted this research in its analysis. These findings have not been confirmed in human clinical trials but raised new dimensions of concern beyond cancer. Neurotoxicity: animal studies have documented TBHQ can cause precursors to certain types of cell injury in neural tissue at high doses, though effects at typical dietary exposure are not established. Allergic reactions including urticaria and contact dermatitis from TBHQ-containing cosmetics and personal care products are documented in dermatology literature. Japan banned TBHQ for food use. The EU restricts it in baby food (completely banned) and in adult food categories with maximum permitted levels. Australia and the UK restrict it.

Got either one in your pantry?

Scan a barcode and we'll flag both Butylated Hydroxyanisole and Tertiary Butylhydroquinone (plus 200+ other ingredients banned overseas).

Scan free →
Sign up free — 5 scans every day →